A Large Open Access Dataset of Brain Metastasis 3D Segmentations with Clinical and Imaging Feature Information https://t.co/0jyX0F4ZJY Exciting work led by @DivyaRamakris19 #ImagineQuant #OpenScience #BrainMets @BraTS_challenge #segmentation #collaboration #radtwitter

As #BrainTumorAwarenessMonth wraps up, we honor all those affected by this disease - patients, caregivers, families. At Neosoma, we're leveraging #AI to provide deeper insights for clinicians and help pave the way for new treatment options. Here's to a future with a cure.

Thank you @theASFNR & @jodytanabe for inviting me to talk on #BigData & #braincancer during the #BrainTumorAwarenessMonth at #ASNR23, featuring #ReSPOND, #GLASS, & @TheASNR-@MICCAI_Society @BraTS_challenge. @MLCommons @Neosoma_ai @intel @Sagebio @LacunaFund @NCIDataSci @RSNA

We believe in supporting Innovative Research to better our patient’s care. We are honored to continue our support of this years @BraTS_challenge in collaboration with @TheASNR and the great team @SpyridonBakas @MariamAboian @moawad_w @ecalabr @RadRudie @AnastasiaJanas & More….

5. 64% perceived using the AI to diagnose time to progression as helpful.

4. 57% of clinicians perceived using the AI to support RANO decision as helpful

3. Using the AI decision support RANO decisions were changed in 44% of cases.

2. On average using an AI-based decision support, the clinicians were able to detect disease progression 1.5 months earlier than without using the AI.

1. The use of an AI based decision support improved the ability of clinicians to detect cancer progression by 15% for both LGGs and HGGs.

This paper was just published in @SNO. Validating our pursuit for clinically actionable AI based insights that are @US_FDA cleared and streamlined in the workflow @NuanceInc @NuanceHealth . @AlyRad_ai @uniklinik_hd @BWHiHub Here are our takeaways :

We are excited about our partnership with @HMHNewJersey to bring cutting edge AI based imaging analytics to brain tumor patients and their care providers.

GROTON, Mass.--(BUSINESS WIRE)--Neosoma, Inc., an innovative medical technology company focused on helping clinicians advance the treatment of brain cancers, announces today it has appointed Debbie Millin and Frederick Driscoll to its board of directors. https://t.co/qHOghXZiFz

Thank you @NJBIZ for sharing the news about this exciting partnership! We look forward to supporting the great work being done @HMHNewJersey through our innovative technologies! @AlyRad_ai @mreyesag

@Neosoma_ai @NuanceHealth So proud of this partnership!

Thank you, @EditorNeuro, for highlighting the tremendous work of the team at @Neosoma_ai. We are dedicated to advancing clinical care and clinical trials for CNS cancers through the use of innovative, reliable, scientifically-validated technologies that prioritize patients and

In need of a framework to handle DICOM-RTSS for DL applications? Check out our new Python package for developing deployable, Radiotherapy-Oriented, DICOM-based auto-segmentation solutions: PyRaDiSe! Paper: https://t.co/VlQwi0kF1y GitHub:

Toward Foundational Deep Learning Models for Medical Imaging in the New Era of Transformer Networks https://t.co/KrJmqfsf2s @StanfordRad @StanfordMed #BERT #DeepLearning #AI

6000 accesses in <7 days! #Federated #MachineLearning enabling the largest #Glioblastoma study to date, without sharing patient data @NatureComms: https://t.co/bzb3B42bhR #OpenSource #NCIITCR @NCIDataSci @FeTS_AI #OpenFL #Healthcare #AI #OpenScience @MeRAQi_lab @IntelAI @Penn

#RSNA22 visit @NuanceInc booth 3300 to see our #NeuroOnc technologies.

Great to see you @AlyRad_ai ! I look forward to using your @Neosoma_ai tools!